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SNARE proteins function at the center of membrane fusion reactions by forming complexes with each other via their coiled-coil domains.
Several SNAREs have N-terminal domains (NTDs) that precede the coiled-coil domain and have critical functions in regulating the fusion
cascade. This review will highlight recent findings on NTDs of syntaxins, the longin domain of VAMP proteins and SNAP-23/25
homologues in yeast. Biochemical and genetic experiments as well as the resolution of several NMR and crystal structures of SNARE NTDs
shed light on their diverse function.D 2003 Elsevier B.V. All rights reserved.Keywords: SNARE; N-terminal domain; Syntaxin; Longin; SM protein; Vam71. Overview
SNARE proteins are key players in eukaryotic membrane
fusion [1–3]. Most SNAREs have a C-terminal transmem-
brane domain and a large cytosolic domain. Once a vesicle
docks to its target organelle, SNAREs localized to both
membranes form defined complexes with each other via
their membrane-proximal coiled-coil, or SNARE, domains
[4,5]. Reconstitution of SNAREs into liposomes suggested
that only specific complexes are capable of fusing mem-
branes [6]. However, it is still a matter of debate whether
such an activity is sufficient to account for the precise and
fast fusion necessary within cells [7,8]. In addition to coiled-
coil domains, several SNAREs have amino (N)-terminal
extensions that can fold independently. This review will
focus on our current understanding of these SNARE appen-
dices as key elements that regulate and coordinate mem-
brane fusion reactions.
Recently, Misura et al. [9] presented a comprehensive
alignment of the N-terminal domains (NTDs) of SNAREs
that were grouped by their SNARE motif. From this, it
becomes apparent that all syntaxins have similar overall0167-4889/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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longin group—Sec22, Ykt6 and VAMP7—also have a
general similarity [10]. However, SNAREs homologous to
SNAP-25 C- or N-terminal helices are more divergent, and
few structures are known.
Here, we will focus on the structure and function of
characterized NTDs. First, we will discuss syntaxins, all of
which have elongated amino-terminal domains consisting of
three helices. The second part will focus on v/R-SNARE
homologues. This group consists of two classes: longins
have a folded N-terminus [10], whereas synaptobrevin-like
v-SNAREs have a short and probably unfolded N-terminus.
In the last part we will discuss a few exceptional cases,
focusing on the vacuolar SNAP-23 homologue Vam7,
which contains a phosphoinositide-binding PX domain. A
close examination of Vam7 reveals evolutionary principles
that may explain its unique character. A summary of the
domains and the nomenclature of SNAREs are given in
Table 1.2. The N-terminal sandwich of syntaxin-like t-SNAREs
The NTDs of syntaxin-like t-SNAREs have been studied
extensively over the last years. A wealth of structural and
biochemical data is now available that illuminates the N
terminus as a regulatory unit. Generally, the NTD of
Table 1
SNAREs with characterized NTDs
Yeast proteins are listed first and have three letter abbreviations and a number. Only biochemically and structurally characterized proteins are listed.
Abbreviations are as follows: PM (plasma membrane), ER (endoplasmic reticulum), EE (early endosome), LE (late endosome), TGN (trans-Golgi network), EE
(early endosome). An asterisk (*) on mVti1b and on syntaxin 6 indicates that these proteins do not belong formally to the syntaxin group, though they have
structural similarities. (**) indicates supporting biochemical, genetic or NMR data if structures have not been solved. Nomenclature of SNAREs according to
Rothman (vesicle-and target organelle SNAREs; [1]) and Fasshauer et al. (based on zero layer of SNARE motif in crystal structure and computer-based
alignments [89,90]: central arginine =R-SNARE, central glutamine =Q-SNARE; [91]) is in brackets. Additional classifications of the Q-SNAREs into the
syntaxin group, the S25N and S25C group (i.e. SNAP-25 N or C-terminal helix) have been suggested [9].
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terminal peptide sequence followed by the Habc domain
(Fig. 1). The Habc domain folds into a three-helix bundle
with a left-handed twist. The plasma membrane syntaxins,
neuronal syntaxin1A and yeast Sso1, have an additionalFig. 1. Localization of the three groups of syntaxin-like t-SNAREs within cells. (A
(orange), coiled-coil domain (blue) and transmembrane domain (TMD; light bl
pathway. For details see text.groove that can accommodate the SNARE motif and con-
vert the protein to a closed conformation. The NTD is
required for several regulatory reactions, including the
variable interaction with Sec1/Munc18 proteins (SM pro-
teins). We will discuss three groups in this context: (1)) Domains are distinguished by colors: N-terminal peptide (red), Habc region
ue). (B) Three classes of syntaxin–SM interactions within the secretory
Fig. 2. Comparison of syntaxin1A (A) and Vam3 (B). Top structures were
rotated by 90j to show the groove within the syntaxin N-terminus (PDB
accession numbers 1EZ3 and 1HS7 [22,44]). Both ribbon and surface
structures are displayed. All structure figures were generated with PyMOL.
L.E.P. Dietrich et al. / Biochimica et Biophysica Acta 1641 (2003) 111–119 113syntaxins that can adopt a closed conformation, (2) syntax-
ins that bind to SM proteins via an N-terminal peptide, and
(3) syntaxins that recognize the SM protein in the context of
a larger protein complex.
2.1. The closed syntaxins
The importance of the Habc domain initially became
apparent with the characterization of syntaxin1A, the t-
SNARE of neuronal presynaptic terminals. Upon isolation,
syntaxin1A is in the closed conformation, in which the NTD
is bound to the coiled-coil SNARE motif. Munc18-1, a SM
protein of the synapse, binds tightly to the closed form of
syntaxin1A in a 1:1 complex that precludes binding of the
presynaptic SNAREs SNAP-25 and synaptobrevin, as well
as a-SNAP [11–14]. When Munc18-1 is bound to syntax-
in1A, synaptic trans-SNARE complexes cannot form. On
the other hand, Munc18-1 is essential, and synapses are
absolutely silent when prepared from mice embryos lacking
Munc18-1 [15]. Another neuronal protein, Munc13/unc13,
binds the N-terminus of syntaxin1A specifically [16].
Munc13 is an essential, multi-domain protein, which con-
tains a phorbol-ester binding C1 domain that is important in
the regulation of vesicle priming by interacting with di-
acylglycerol [17–19]. It is possible that Munc18-1 and
Munc13 cooperate to protect and guide syntaxin1A prior
to the formation of trans-SNARE complexes: (i) Munc18-1
would first bind syntaxin1A in the closed form. (ii) This is
then converted to the open form by an unknown mecha-
nism, which is stabilized by Munc13. (iii) The open syntax-
in1A would then participate in trans-SNARE complexes
that form prior to membrane fusion. This model is supported
by the observation that syntaxin1A mutants that are consti-
tutively open do not bind Munc18-1 and inhibit exocytosis
[20]. Interestingly, in C. elegans a requirement for Unc13
becomes dispensable if syntaxin1A is present as a constitu-
tively open mutant [21]. However, a sequential reaction of
Munc18-1 and Munc13 has not yet been shown, and the
transition of the closed to the open form of syntaxin1A
awaits further analysis.
There are strong similarities between syntaxin NTDs.
Both syntaxin1A and its homologue at the yeast plasma
membrane, Sso1, have a groove in their NTD that is adapted
to accommodate the coiled-coil motif (Fig. 2A; Refs. [22–
24]). Assembly of SNARE complexes in vitro is accelerated
2000-fold in the absence of the Sso1 NTD [25], and fusion
of liposomes carrying synaptic SNARE proteins is promot-
ed if the syntaxin1A NTD is removed [26]. This indicates
that the closed conformation of syntaxin1A and Sso1 is
inhibitory for fusion, but in both cases it seems that the
closed conformation is also an important intermediate that
prevents fast SNARE pairing. Sso1 requires the N-terminus
for yeast viability [23] even though a constitutively open
Sso1 can bind efficiently to Sec9, a yeast SNAP-25 homo-
log. If Sec9 is overexpressed in this mutant, the cells
become sick, indicating that the syntaxin’s ability to forma closed conformation is essential for productive SNARE
complex formation [27]. Despite the similarity between
syntaxin1A and Sso1, proteins that bind the N-terminus of
Sso1 have yet not been identified. Furthermore, what
appeared to be the paradigm for binding of syntaxins to
SM proteins—the syntaxin1A/Munc18-1 interaction—
turned out to be an exceptional case. Sso1 does not form
a binary complex with its SM protein Sec1, rather, they only
interact in the context of the SNARE complex [28]. Binding
of Sec1 to Sso1 in vitro is very poor, in contrast to the tight
interaction of Munc18-1 and syntaxin1A [13,14,28]. Fur-
thermore, though Sec1 apparently binds Sso1 in the SNARE
complex, it actually has not yet been tested whether Sec1
still binds to the SNARE complex if Sso1 lacks its N-
terminus. Since it accumulates at sites of secretion [28],
Sec1 binding may enhance exocytosis by altering the trans-
SNARE complex [29]. Fast exocytosis in the synapse seems
to require guidance of syntaxin1A by its direct binding to
Munc18-1. Whether this is a very specialized case or could
be similar to Sec1’s enhancement of fusion at the yeast
plasma membrane remains to be seen. An in vitro fusion
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could become helpful to clarify the role of Sec1.
Recently, it was shown that syntaxin7, a syntaxin of the
late endosome, also adopts a closed conformation [30].
Syntaxin7 forms a SNARE complex with Vti1b, syntaxin8
and endobrevin [31,32]. Removal of the NTD of syntaxin7
accelerates SNARE complex assembly in vitro sevenfold.
However, known SM proteins do not bind the N-terminus of
syntaxin7 in a two-hybrid assay [33]. A function of syntax-
in7’s NTD and its role in endosome fusion awaits further
analysis.
2.2. The open syntaxins with an N-terminal peptide motif
required for SM binding
Within the secretory pathway, between the endoplasmic
reticulum (ER) and the endosome, several syntaxins interact
with SM proteins via an unexpected mechanism. These
syntaxins have amino-terminal domains comparable to syn-
taxin1A, but which lack the central groove required for an
interaction with the coiled-coil domain [9,33,34]. They also
have an unstructured f 30-amino-acid peptide stretch,
which precedes the three-helix bundle of the Habc domain.
It is now clear that some SM proteins recognize and bind
this peptide specifically. At the ER and Golgi, the SM
protein Sly1 binds to the syntaxins Ufe1 and Sed5, and
the endosomal SM protein Vps45 interacts with Tlg2/
syntaxin16 [33,34]. Binding of SM proteins to the N-
terminal peptide has functional consequences. At the Golgi,
the Sly1 interaction with Sed5 occurs in the context of the
SNARE complex and contributes to the specificity of
SNARE complex assembly [35,36]. Structural studies on
the interaction of Sly1 with Sed5 were recently published
[37,38]. Strikingly, Sly1 binds to the Sed5 N-terminal
peptide via an autonomously folded N-terminal part. This
interaction is distinct from the previously discussed binding
of Munc18-1 to syntaxin1A, since it occurs on the opposite
face of the SM protein [37,38]. At the endosome, Vps45
binds and stabilizes Tlg2 and is necessary to permit SNARE
complex assembly in vivo [39,40]. Structural considerations
suggest that Vps45 binds to Tlg2 like Sly1 to Sed5 [37,38].
Interestingly, a Tlg2 mutant lacking the NTD can partially
bypass the requirement for Vps45 [40]. These data suggest
that binding of SM proteins to the N-terminal peptide
activates and chaperones the SNARE to the trans-SNARE
complex1.
2.3. The late secretory pathway syntaxins and complexed
SM proteins
In the late endocytic pathway, the interactions between
the NTD of the syntaxins Vam3 and Pep12 with the SM
proteins Vps33 and Vps45, respectively, appears to be1 Differential binding of SM protein Vps45 to Tlg2 has recently
suggested by N.J. Bryant and D.E. James, J. Cell Biol. 161 (2003) 691–696.indirect. In contrast to all previously discussed SM proteins,
Vps33 has not been found as a monomer but as part of a
large complex, the Class C Vps or HOPS complex [41–43].
Vam3 contains a shorter N-terminal three-helix bundle
without a syntaxin1A-like groove (Fig. 2B; Ref. [44]).
The N-terminus of Vam3 is not essential, but mutant
vacuoles fuse with markedly reduced efficiency [45]. This
is probably due to its poor interaction with the Vps33-
containing Class C Vps/HOPS (homotypic fusion protein
sorting) complex [45], an essential docking factor [46,47].
Based on in vivo associations, it has been suggested that the
HOPS complex binds exclusively to unpaired Vam3 [48].
Even though it remains to be shown when such an inter-
mediate occurs during the vacuole fusion reaction, it appears
that the interaction of Vam3 and the HOPS complex is
required to allow a coordinated transition from priming to
docking. However, not all studies agree that the NTD of
Vam3 is essential for this. It has been shown that antibodies
to the Vam3 N-terminus do not block vacuole fusion [49].
This is a difficult argument, though, as it is unclear if the
antibody recognized its membrane bound target. In the same
study, the reduction in vacuole fusion with truncated Vam3
was not as significant as in our studies. Furthermore, the
coiled-coil domain of Vam3 can also bind monomeric
Vps33 [44], but it is uncertain whether this interaction also
occurs in vivo, as a function of monomeric Vps33 has not
yet been reported. Thus, even though the biochemical
evidence for a role of the NTD of Vam3 is strong, unravel-
ing an accurate picture will require further studies.
Little is known about the function of the amino terminus
of the endosomal syntaxin Pep12. Like the Vam3 N-termi-
nus, it contains a folded three-helix bundle and does not
adopt a closed conformation, but lacks the N-terminal
peptide found in Tlg2 [34]. Pep12 has been identified in a
complex containing the SM protein Vps45, the FYVE-
domain protein Vac1 (a tethering factor similar to mamma-
lian EEA1 and rabenosyn) and the Rab GTPase Vps21
[39,50–53], but a direct binding of Vps45 to Pep12 has not
been observed [33]. A close characterization of this complex
is again hampered by the lack of an in vitro assay. Thus, it
remains to be established whether and how the N terminus
of Pep12 binds to this complex and at which time during
fusion the complex forms. Previous analysis of vacuolar and
endosomal SNARE complexes in the sec18-1 temperature-
sensitive mutant (Sec18 is the ATPase necessary to disas-
semble SNARE complexes) indicated that complexes ob-
served in vivo may not correspond to intermediates of a
fusion reaction but are most likely the result of a completed
fusion reaction [54,55].
The intense efforts to unravel structures and functions of
the NTDs of syntaxin-like t-SNAREs allow us to deduce
some common themes. All syntaxins characterized to date
contain an N-terminal three-helix bundle. The possibility of
forming a closed conformation by binding to the SNARE
motif is reserved for the plasma membrane syntaxins. SM
proteins are the major binding partners of the NTD. The
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(Sso1 and syntaxin1A), but more common is the binding to
the unstructured N-terminal peptide. It appears as if all SM
proteins that show a direct binding to the syntaxin are
required to chaperone activated t-SNAREs. The intermedi-
ate may be required to allow specific assembly of trans-
SNARE complexes [35], prevent degradation of the unsta-
ble intermediate [40] or trigger fast exocytosis [8]. So far, it
is uncertain whether such a mechanism also functions at the
late endosome or vacuole, where SM proteins act in the
context of larger protein complexes. Specific interactions
between the SM proteins Vps45 and Vps33 and the NTD of
Pep12 and Vam3, respectively, have not been discovered.
One provocative hypothesis is that the NTD of syntaxins
functions as an anchor to guide SM proteins to their site of
action.3. Longin domains
In the late 1980s, VAMP [56] and its homologue syn-
aptobrevin [57] were isolated as vesicle-associated proteins
from synapses and predicted to be crucial for vesicular
transport. Today they define a group of SNARE proteins
that share sequence homology, in particular the highly
conserved arginine, within their coiled-coil/SNARE motifs.
They are also known as v-SNAREs or R-SNAREs.Fig. 3. Structure of the NTDs of longins. (A) Ykt6 structure (PDB accession nu
highlighted in red. h-sheets are in blue, a-helices in yellow. (B) DALI structural ali
green. Note that the Sec22 sequence was modified by the DALI program: X corrThe amino termini of proteins in the VAMP/synaptobre-
vin family are diverse, ranging in length from a few
(synaptobrevin) up to 150 residues (Sec22). It was only
recently recognized that some of the long NTDs (f 150 aa)
share significant sequence homology [10]. This resulted in
further classification of these VAMP/synaptobrevins as
longins, allowing the others with less conserved N-termini
to be referred to as brevins. Information on the N-termini of
brevins is scarce and awaits further analysis. Here, we will
focus on recent studies on the longin family. Bioinformatic
analysis predicted that longin domains share the same
secondary structure [10]. This was confirmed by two
studies, which solved the crystal structures of the NTDs
of the R-SNAREs mouse Sec22b [58] and yeast Ykt6 [59].
Both longin domains were shown to adopt the same fold, a
globular domain with a five-stranded h-sheet that is sand-
wiched by an a-helix on one side and two a-helices on the
other (Fig. 3A). The same arrangement is also found in the
actin-regulating protein profilin [60], GAF/PAS regulatory
modules [61] and the tethering factor SEDL [62].
Surprisingly, while longins are conserved in all eukar-
yotes, sequence similarity searches suggest that other
VAMP/synaptobrevins are lacking in plants [10]. This
indicates that the R-SNARE motif of longins can substitute
for that of brevins. Since longins are the only VAMP/
synaptobrevin-type found in all eukaryotes, their NTD
appears to be essential.mber 1H8M, [59]). F42 that is essential for autoinhibition of Ykt6 [59] is
gnment of the NTDs of Sec22b and Ykt6. Identical residues are indicated in
esponds to M (methionine).
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addressing the longin domains of Ti-VAMP (VAMP7) and
Ykt6, suggest an autoinhibitory mechanism that is reminis-
cent of syntaxins that can adopt the closed conformation, as
discussed in the previous section. Galli and coworkers
showed that expression of an N-terminally deleted Ti-
VAMP supports neurite outgrowth of neurons in primary
culture, whereas overexpression of the NTD of Ti-VAMP
has the opposite effect [63]. This was the first indication that
longin domains exert a regulatory function. Zhang and
coworkers demonstrated that the longin domain of Ykt6
contains a hydrophobic patch with which it can bind its
SNARE motif [59]. The mutation of a crucial residue within
this patch, F42E, was sufficient to abrogate this interaction
in an in vitro binding assay. Since the same mutation
conferred a loss-of-function phenotype in vivo, an auto-
inhibitory mechanism of the NTD was suggested. In con-
trast, for Sec22 an interaction between the longin domain
and the SNARE motif was shown to be unlikely [58].
Interestingly, like Ykt6, Sec22 also contains a hydrophobic
patch in a similar spatial orientation, but at the position of
the crucial Phe in Ykt6, Sec22 contains a serine (Fig. 3B).
Since the F42E mutation in Ykt6 prevents an interaction
between longin domain and SNARE motif, the structural
comparison nicely confirms the negative binding results for
Sec22.
Based on these data, the autoinhibitory function of Ykt6
and Ti-VAMP NTDs seems not to be a unifying feature of
longins. As a consequence, the same fold, i.e. the profilin-
like domain, can adopt different functions. Significantly, the
same fold in profilin—without any sequence homolog to
longins—has an entirely different function. Based on a
structural comparison between Sec22’s longin domain and
profilin, Sec22 is unlikely to mediate functions of profilin
(like the interaction with proline-rich sequences, actin or
phosphoinositide phosphates) [58]. An analogous structural
comparison between Ykt6 and profilin suggests the same
(Fig. 3).
Recently, a structural study on the tethering factor SEDL
revealed a fold shared with Sec22-Ykt6, but also with no
sequence homology [62]. Is the longin/profilin-fold then
merely a structural scaffold that allows a variety of functions
depending on its environment? Or, does the special se-
quence conservation of the longin domain encode a unifying
function that remains to be identified? While this issue has
not been resolved, interesting players regarding the function
of the longin domain are the mammalian isoforms Sec22a
and Sec22c [64–66]. Both are unlikely to be SNARE
proteins since their C-terminal extensions are not predicted
to form coiled-coil domains [67]. Their existence suggests a
function for the longin domain that exceeds the role of a
SNARE-regulating domain, as it may even function without
the SNARE motif. Whether or not these two proteins are
involved in membrane fusion and whether the longin
domain exerts additional functions independent of fusion
remains to be clarified.4. Unusual NTDs
Structural and functional analyses have revealed con-
served features of the syntaxin and the longin families. In
the last part, we will discuss three yeast proteins of the
SNAP-25/23 family, which also have N-terminal exten-
sions: the vacuolar SNARE Vam7, and the plasma mem-
brane SNARE Sec9 and its homolog Spo20. In contrast to
all previously discussed SNAREs that are bound to the
membrane via a C-terminal transmembrane domain or lipid
anchor, Vam7, Sec9 and Spo20 contain neither. They share a
similar coiled-coil domain, but the functions of their N-
termini are divergent. In this part we will focus primarily on
the vacuolar SNARE Vam7 and briefly discuss illuminating
findings on Sec9 and Spo20.
4.1. Vam7 function on the vacuole
The vacuolar SNAP-23 homologue Vam7 belongs to the
t/Q-SNARE family and is part of the vacuolar SNARE
complex. Vam7 is required for vacuole fusion and mainte-
nance of vacuolar integrity since vacuoles are fragmented in
the absence of Vam7 [48,68,69].
Vam7’s NTD contains a PX domain. PX domains (named
after the NADPH oxidase subunits p40phox and p47phox)
were identified as novel phosphatidylinositol phosphate
(PtdIns-P) binding proteins, most of them having a prefer-
ence for PtdIns-3-P [70,71]. Several yeast proteins with PX
domains, including Vam7, bind to PtdIns-3-P [72,73]. The
PX domain consists of a module of three h-strands and three
to four a-helices that binds to the phosphoinositide (Fig. 4;
Ref. [74]). Binding to phosphoinositides may insert part of
the PX domain into the lipid bilayer, similar to the lipid
insertion seen for the FYVE domain (M. Overduin, personal
communication). So far, it is unclear whether PX domains
also undergo specific protein–protein interactions. The
binding affinity of the PX domain to membranes has not
been determined precisely, but Vam7 resists membrane
extraction by carbonate or urea [69]. It is likely that the
interaction of the coiled-coil domains of Vam7 and Vam3
contributes to the tight membrane association.
In yeast, Vam7 is found both on the vacuole and in the
cytosol. Inhibition of Sec18p in vivo shifts most of Vam7 to
the vacuole [68]. We could show that Vam7 moves between
the vacuole membrane and the cytosol [75]: during ATP/
Sec18-dependent priming, up to 90% of Vam7 gets released
from the vacuole membrane into the cytosol as a monomer.
The released Vam7 is a functional intermediate, as it can
rescue fusion of vacuoles depleted of Vam7. In agreement
with Cheever et al. [72], we found that Vam7 required its
PX domain for this rescue. Since the C-terminal coiled-coil
domain of Vam7 and a Vam7 protein mutated in its PX
domain do not rescue fusion, it is likely that association of
the PX domain to a phosphoinositide target is a prerequisite
for the migration of Vam7 into the fusion site. We do not
know whether PtdIns-3-P is sufficient to allow Vam7
Fig. 4. Structure of the PX domain of Vam7 (PDB accession number
1KMD; [74]). The critical Y42 [68,72] that may bind directly to PtdIns-3-P
is shown in red. Color code as in Fig. 3.
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primed. This indicates that either all PtdIns-3-Ps are occu-
pied, have not been generated, or binding can only occur
when a Vam3 protein–protein interaction site is available.
Thus, even though we know the major lipid-binding site of
Vam7, we are far from understanding the regulation of
Vam7 movement between the cytosol and the vacuole.
4.2. Phosphoinositides, acylation and SNARE protein
function
Phosphoinositides are involved in a broad range of
cellular processes including membrane trafficking along
the secretory pathway, the cell cycle and autophagy. Severalconserved domains bind to PtdIns phosphates, such as the
PH (pleckstrin homology) domain, the ENTH (epsin N-
terminal homology) domain, the FYVE (Fab1p, YOTB,
Vac1 and EEA1) domain, the FERM domain (band 4.1,
ezrin, radixin and moesin) and the PX domain [70,76].
Several PX domain-containing proteins have functions in
protein sorting, for example the yeast proteins Vps5 and
Vps17. Both proteins are part of the retromer complex that
is required for transport of proteins from the endosome to
the Golgi [77–80]. Interestingly, coiled-coil domains in
Vps5 and Vps17 flank the PX domain C-terminally, similar
to the domain arrangement of Vam7. It is likely that such an
orientation is determined by the binding mode of the PX
domain to lipid membranes. So far, it is not clear why Vam7
is the only known SNARE (with the exception of two
potential homologues in the yeasts S. pombe and C.
albicans), which requires a PX domain normally found in
proteins essential for sorting along the secretory pathway.
We hypothesize that the PX domain of Vam7 represents a
phosphoinositide-binding module that is essential for each
membrane fusion machinery. On other organelle mem-
branes along the secretory pathway, these modules are
found in tethering factors like mammalian EEA1 or yeast
Vac1/rabenosyn5, raising the possibility that lipid domains
have a role at the fusion site. Indications for such a domain
are few. Ergosterol and PtdIns-4,5-P2 are required for
vacuole fusion [81,82], but any connection to the function
of the Vam7 PX domain has not yet been established. To
date, Vam7 is the only PtdIns phosphate-binding protein
required for vacuole fusion, although it is likely that PtdIns-
4,5-P2 also has a protein target [82]. Thus, it seems that for
each membrane fusion reaction, at least one protein has a
key function to guide and sort others to defined lipid
domains. Proteins required for PtdIns-P synthesis and
turnover could therefore have key functions in membrane-
fusion reactions.
The mammalian SNAREs SNAP-23 and, to some extent,
SNAP-25 show homology in one of their two SNARE
motifs to the Vam7 coiled-coil domain. Both proteins lack
TMDs, but are anchored to the membrane by palmitoylation
[83,84]. Like Vam7, SNAP-23 cycles between membranes
and the cytosol [85,86], a movement possibly associated
with a palmitoylation/depalmitoylation switch. We speculate
that Vam7 function as a mobile SNARE has been preserved
during evolution by transferring the PtdIns phosphate bind-
ing to tethering factors and anchoring the SNARE motif by
palmitoylation.
4.3. Determining specificity by the N-terminus: Sec9 and
Spo20
During exocytosis, Sec9, the SNAP-25 homologue at
the yeast plasma membrane, acts together with the syn-
taxin-like t-SNARE Sso1. During spore formation, Sec9
gets replaced by Spo20, which is 40% homologous to
Sec9 and essential for sporulation [87]. Interestingly,
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the NTDs appear to have distinct functions. Replacement
of the Sec9 N-terminus by the one of Spo20 inhibits
vegetative growth, while the Sec9 amino-terminus can be
removed and does not affect fusion [88]. These studies
underline the importance of these NTDs, and it will be
interesting to see what structural data on these proteins
will contribute to understanding what seem like significant
functional differences.5. Concluding remarks
Numerous structural, genetic and biochemical studies
have provided insight into the role of the NTDs of SNARE
proteins. The N-terminal three helical bundle of syntaxin-
like t-SNAREs appears to be a conserved feature of this
protein group, as does the profilin like fold for longins.
There are several challenges for future research. The con-
servation of Sec1 proteins and their relation to the NTDs of
syntaxin-like t-SNAREs is obvious in some cases, but the
common function of Sec1 proteins remains to be solved.
Equally, the conservation of the longin domain of Sec22,
Ykt6 and Ti-VAMP is striking, though it is likely that their
function will exceed the autoinhibitory role described for
Ykt6 and Ti-VAMP. Structures of the NTDs of other v-
SNAREs are not available, nor is it known whether they
form autonomous domains. Future studies will certainly
unravel many of these questions and provide unexpected
insight into the emerging picture of SNARE protein func-
tion beyond SNARE motifs.Acknowledgements
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